GPS Air

GPS Air, formerly known as Global Plasma Solutions, is an American indoor-air-quality technology company serving residential, commercial, and industrial buildings. The company was founded in Savannah, Georgia, in 2008 as a sales-focused air-purification business built around needlepoint bipolar ionization, which it has also described as needlepoint bipolar cold plasma or soft ionization. Its products are designed for installation in heating, ventilation, and air-conditioning systems as well as directly in occupied rooms. The company’s central technology generates positive and negative ions intended to interact with airborne particles and microorganisms. GPS Air has marketed the approach as a way to improve indoor air quality and reduce contaminants including microorganisms, mold, allergens, and odors. Its portfolio has included in-duct equipment, room-mounted air purifiers, and plasma-generating devices for different building environments. One cited product is the GPS-iClean room-air-purification system, which received an IAQ Gold award in The ACHR News’s 2016 Dealer Design Awards. Another product, the GPS-FC24-AC, has been described as a room-mounted or HVAC-compatible unit that can be installed in multiple small cassettes or connected to existing air-conditioning equipment. In October 2018, investment firm Falfurrias Capital Partners acquired the company, after which its headquarters moved from Savannah to Charlotte, North Carolina. In July 2022, the business formally changed its brand name from Global Plasma Solutions to GPS Air. The rebranding was intended to express a broader focus on building indoor air quality rather than emphasizing plasma terminology alone. GPS Air experienced a substantial increase in attention during the COVID-19 pandemic. Schools, public facilities, and other organizations in the United States sought technologies that could supplement ventilation and help address airborne health concerns. The company’s ionization devices were installed in numerous locations, including schools and municipal facilities, in some cases using COVID-19 relief funds. The heightened adoption also brought intensified examination from journalists, engineers, public-health organizations, building-science specialists, and academic researchers. Critics questioned whether the performance demonstrated in company-sponsored or limited laboratory tests could be reproduced in ordinary occupied spaces. Concerns included the gap between ion concentrations used in certain tests and the lower concentrations reportedly produced during routine operation, as well as the possibility that ionization could generate undesirable by-products or create health risks at sufficiently high levels. Investigations and studies associated with Boeing, academic researchers, and indoor-air-quality specialists produced differing findings, with later or independent work raising doubts about the strength of efficacy claims. GPS Air disputed some criticism, including arguments that particular tests examined pathogens on surfaces rather than airborne organisms. The scientific and commercial controversy generated multiple lawsuits. GPS Air brought claims against critics and publishers, including ASHRAE member Marwa Zaatari, indoor-environmental consultant Francis J. Offermann, and academic publisher Elsevier. Consumers also brought class-action litigation in Delaware alleging misleading claims about effectiveness against COVID-19 and the extent of independent testing. The litigation produced several dismissals and rulings concerning standing, evidence, and class certification. The final Delaware class-action claims were described as having been decertified and dismissed in July 2026 after plaintiffs could not connect device serial numbers to specific purchasers. GPS Air remains associated with the indoor-air-treatment market, but its technology and marketing claims continue to be treated as subjects requiring careful evaluation against independent scientific evidence.

GPS Air originated in 2008 in Savannah, Georgia, under the name Global Plasma Solutions. It was established as an air-purification sales company whose products centered on needlepoint bipolar ionization, a form of soft ionization also described by the company as needlepoint bipolar cold plasma. The basic proposition was that positive and negative ions introduced into an indoor environment could interact with airborne particles and microorganisms and contribute to cleaner indoor air. From its early operations, the company targeted a broad range of enclosed spaces rather than a single building category. Its systems were intended for residential, commercial, and industrial applications and included equipment that could be installed inside air-conditioning and ventilation systems as well as products intended for direct room use. The company also marketed applications involving mold, allergens, odors, and microorganisms. This positioning placed GPS Air within the expanding indoor-environment and building-services technology sector rather than the conventional consumer-appliance market alone. The company’s profile grew after its GPS-iClean device received an IAQ Gold award in The ACHR News’s 2016 Dealer Design Awards. The recognition reflected interest from heating, ventilation, air-conditioning, and refrigeration dealers in air-treatment products that could be integrated into building systems. Nevertheless, the company remained privately held and relatively specialized compared with large consumer air-purifier manufacturers. A major corporate transition occurred in October 2018, when Falfurrias Capital Partners acquired Global Plasma Solutions. Following the transaction, the company moved its headquarters to Charlotte, North Carolina. The acquisition provided an investment-firm ownership structure and coincided with the company’s continued development of products for HVAC integration and room-level treatment. The COVID-19 pandemic transformed the commercial environment for the company. In 2020 and 2021, schools, local governments, and private organizations sought additional methods of addressing indoor-air concerns. GPS Air’s ionization devices were installed in numerous facilities, including schools, and some purchases were supported by pandemic-relief funding. The sudden expansion of the customer base made the company’s performance representations much more consequential, particularly claims concerning the reduction or inactivation of microorganisms in occupied spaces. At the same time, journalists, engineers, researchers, and professional organizations questioned the evidentiary basis for some of the claims. A recurring issue was whether testing performed under highly controlled or unusually concentrated ion conditions could be extrapolated to ordinary rooms. Material describing the company’s testing indicated that an early test used a very small chamber and a high ion concentration. Later commentary noted that routine operating concentrations could be substantially lower. Studies associated with Boeing and the University of Arizona produced findings that were interpreted differently by the company and its critics, while other researchers questioned effectiveness and raised concerns about potentially harmful by-products or excessive ion levels. The controversy resulted in regulatory and institutional caution as well as litigation. Scientists and engineers circulated an open warning about ionization technology, and organizations including the Asthma and Allergy Foundation of America and the Environmental Protection Agency were described as expressing concerns about possible health effects. The Centers for Disease Control and Prevention prompted advice to educational authorities emphasizing stronger scientific evidence before schools purchased such devices. Some school systems reportedly removed or reconsidered installations after the criticism became public. GPS Air responded through public arguments and legal action. It sued critics including ASHRAE member Marwa Zaatari and indoor-environmental consultant Francis J. Offermann, and it also sued Elsevier over publication of research critical of the company’s devices. Consumers separately pursued Delaware class-action claims alleging false or misleading advertising concerning COVID-19 performance and independent testing. The first Garner case was dismissed in 2022 on standing grounds. Later proceedings dismissed some claims, denied certification for others, and temporarily certified a narrower claim related to independent testing before the case was ultimately decertified and dismissed in July 2026 because purchasers could not be connected to device serial numbers. In July 2022, Global Plasma Solutions adopted the GPS Air name. The change signaled an effort to present the business as a broader indoor-air-quality company rather than one defined primarily by plasma terminology. GPS Air continues to be identified with ionization-based air-treatment products for HVAC systems and occupied rooms, while the scientific basis, safety, and marketing of those technologies remain important parts of the company’s public history.

• 2026

  Delaware class-action litigation dismissed

  [1]GPS Airen.wikipedia.org

  The remaining Delaware class-action claims were described as decertified and dismissed after plaintiffs could not establish purchaser standing through device serial-number records.

• 2022

  Global Plasma Solutions becomes GPS Air

  [1]GPS Airen.wikipedia.org

  The company formally changed its brand name to GPS Air to reflect its wider indoor-air-quality positioning.

• 2020

  Pandemic-era expansion

  [1]GPS Airen.wikipedia.org

  Demand for indoor-air-quality technologies increased sharply, and GPS Air devices were installed in schools and public facilities across the United States.

• 2018

  Acquisition by Falfurrias Capital Partners

  [1]GPS Airen.wikipedia.org

  Falfurrias Capital Partners purchased the company in October, and the headquarters moved to Charlotte, North Carolina.

• 2016

  GPS-iClean receives IAQ Gold recognition

  [1]GPS Airen.wikipedia.org

  The GPS-iClean room-air-purification device received an IAQ Gold award in The ACHR News’s Dealer Design Awards.

• 2008

  Company founded in Savannah

  [1]GPS Airen.wikipedia.org

  Global Plasma Solutions was founded in Savannah, Georgia, as an air-purification sales company focused on needlepoint bipolar ionization.

Indoor-air-quality technology provider focused on ionization-based air treatment for homes, commercial properties, industrial facilities, schools, and other enclosed environments.

• Room air purification

  GPS-iClean

  The GPS-iClean is a room-air-purification product associated with GPS Air’s ionization-based approach. It was designed for use in enclosed indoor spaces and was recognized with an IAQ Gold award in The ACHR News’s 2016 Dealer Design Awards. The product represents the company’s room-level offering, complementing equipment intended for installation in HVAC and ventilation systems.

• Room-mounted and HVAC-compatible air treatment

  GPS-FC24-AC

  The GPS-FC24-AC is described as a room-mounted air purifier that can be installed using multiple small cassettes or connected to existing HVAC equipment. It is intended to provide ionization-based treatment in small or distributed configurations, allowing deployment in rooms or as part of a building’s air-handling infrastructure.

• Indoor-air-quality equipment

  GPS Air plasma generators

  GPS Air has sold plasma-generating devices promoted for reducing airborne microorganisms, mold, and allergens. The products are positioned for indoor environments, including applications intended to support healthier air for occupants and pets. Their underlying ionization technology became the focus of scientific debate concerning real-world efficacy, ion concentrations, and possible by-products.

• 2021

  Scientific and public controversy over ionization claims

  During the COVID-19 pandemic, scientists, engineers, journalists, and public-health organizations questioned whether GPS Air’s needlepoint bipolar ionization devices were effective under normal operating conditions. Critics highlighted the difference between high ion concentrations used in some tests and concentrations reportedly produced in ordinary rooms, while also raising concerns about possible negative health effects and by-products. Some schools and public bodies reconsidered or removed installations.

  Source

• 2021

  Lawsuits against critics and academic publisher

  GPS Air filed lawsuits against ASHRAE member Marwa Zaatari, indoor-environmental consultant Francis J. Offermann, and academic publisher Elsevier over criticism and published research concerning the company’s products. The actions became part of broader debate about scientific evidence, public criticism, and marketing claims.

  Source

• 2021

  Consumer class-action litigation over COVID-19 marketing

  Consumers alleged that GPS Air marketed its ionization products with unsupported claims about inactivating COVID-19 or other microorganisms and misrepresented the extent of independent testing. Delaware proceedings involved disputes over standing, evidentiary support, and class certification.

  Source

Read more

• 2022

  Rebrand from Global Plasma Solutions to GPS AirStrategy

  Background

  The former name emphasized plasma technology, while the company served a broader indoor-air-quality market.

  Action taken

  The company formally adopted GPS Air as its brand name in July 2022.

  Aftermath

  The new name positioned the company around building indoor-air-quality technology rather than a single technical terminology.

  Source

• 2018

  Accept acquisition by Falfurrias Capital PartnersM&A

  Background

  Global Plasma Solutions was acquired by the investment firm Falfurrias Capital Partners in October 2018.

  Action taken

  Ownership changed and the company relocated its headquarters from Savannah to Charlotte.

  Aftermath

  The business continued developing and selling ionization-based indoor-air-quality products under private ownership.

  Source

1. 1GPS Airen.wikipedia.org